logo
Share SHARE
FONT-SIZE Plus   Neg

IGI Laboratories Names Jason Grenfell-Gardner CEO

IGI Laboratories, Inc. (IG) Monday said Jason Grenfell-Gardner has been appointed President and Chief Executive Officer of the firm, effective July 30.

Jason Grenfell-Gardner brings significant experience in the pharmaceutical industry, with a special focus on generics. He was most recently the Senior Vice President of Sales and Marketing for West-Ward Pharmaceuticals, the US Subsidiary of Hikma Pharmaceuticals.

Jason had a key role in the senior management team there, which grew the business from just over $100 million in 2008 to over $300 million in 2011. He strengthened West-Ward's presence in the sterile injectable space through the acquisition of Baxter International, Inc.'s multisource injectable business in 2011.

Jason originally joined Hikma Pharmaceuticals to lead its initial public offering in 2004, and later headed its business development efforts.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Walt Disney Co. (DIS) is reportedly in talks to buy a stake in Major League Baseball Advanced Media. According to LA Times, citing people with knowledge of the matter, Disney is seeking to acquire one-third interest in the MLB.com, which develops and manages the league's digital products. The deal... Postal Savings Bank of China, one of the biggest banks in China, seeks to raise about $8 billion in an initial public offering, which could be the biggest IPO of the year. Postal Savings Bank of China plans to list its stock in the Hong Kong stock exchange. According to reports, the Postal Savings... Sporting goods retailer Dick's Sporting Goods, Inc. has emerged as the successful bidder in the bankruptcy auction for its former rival Sports Authority Holding Inc.'s intellectual property assets and the right to acquire 31 store leases.
comments powered by Disqus
Follow RTT